
Rua Gold submits Auld Creek gold-antimony fast-track application
The New Zealand proposal seeks mine and infrastructure approvals, with a feasibility study targeted for the fourth quarter of 2026.

Promontorio Sur returned 12.20 metres at 238 grams per tonne silver equivalent, with an updated resource targeted for the fourth quarter.

The New Zealand proposal seeks mine and infrastructure approvals, with a feasibility study targeted for the fourth quarter of 2026.

Quarter-end cash, restricted cash and deposits totalled US$840.6 million before the October CanAdelaar acquisition.
Armenia's conditional authorizations cover previously treated metastatic colorectal cancer; existing financing supports operations into 2027.
Assays confirm mineralization 500 metres beyond the deposit and higher grades inside Hurricane's southern resource shell.

The developer has about US$780 million in unrestricted cash and expects its first HPC revenue in 2027.

The proposed share deal would give Aya about 19.11 per cent of Sama and add Moroccan tungsten, copper and molybdenum exposure.

The 353-patient VOCAL study tested three-times-weekly vadadustat, a regimen that remains investigational despite Vafseo's daily-use approval.

Recorlev revenue grew 93 per cent as Xeris lifted its annual forecast and kept a pivotal thyroid study on track for year-end.
Quarterly capital spending reached US$985.1 million, while the company targets early 2027 completion of its first colocation buildout.
The planned sale excludes EES Coke, while DTE’s 2027 earnings baseline assumes a closing earlier than the announced target.
The pipeline operator sets a 2027 net capital spending range of C$6B to C$6.5B and approves Midwest expansions targeting 2030 service.
Shoals holders would receive 1.6931 ARRAY shares per share and own about 65% of the combined company, with closing targeted for early 2027.
A US$36M tariff benefit lifted gross margin, while net cash and investments slipped and fourth-quarter sales guidance came in lower.
Management estimates up to US$2.5 million in additional survey work over two years, subject to successful delivery and further awards.
The company says current assets exceeded current liabilities in October, while Australian admission still requires ASX review and approval.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
Baseline work will support environmental assessment and licensing as the company targets a pre-feasibility study for the first half of 2028.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
The neuroscience developer expects epilepsy safety data this quarter and FDA talks on its bipolar mania program in early 2027.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Medical-only quarterly results limit year-over-year comparisons as Trulieve reports a US$65 million mortgage repayment after September.
A definitive Fluor construction agreement covers three Kentucky buildings, with phased completions expected from late 2027 through mid-2028.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Available liquidity stood near US$700M at Sept. 30 as the company advanced a US$2.3B Great Basin expansion targeting service in late 2028.

The Anais dyke interval includes 142 metres at 1.97 per cent lithium oxide, with true thickness estimated at about 80 per cent of drilled length.

The generator forecasts US$1.5B to US$1.75B in adjusted free cash flow for 2027 as acquired plants contribute a full year.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cash reached US$48.2 million as licensing supported operations, while approaching hemp restrictions threaten current products.

The company identifies its entire Florida retail network, while federal security, inventory and recordkeeping requirements continue.

The psilocybin developer expects its final application submission within two weeks, with a launch targeted for the first half of 2027.

The company confirms federal registrations but does not disclose how many dispensaries received them or identify their locations.